MR imaging findings in hepatic encephalopathy

American Journal of Neuroradiology

Volumn 29, Issue 9, 2008, Pages 1612-1621

  Rovira Cañellas, Alex ^a   Alonso, J ^a,b   Cordoba J ^a,b,c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; MANGANESE;

BRAIN EDEMA; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; GLOBUS PALLIDUS; HEPATIC ENCEPHALOPATHY; HOMEOSTASIS; HYPERAMMONEMIA; IMAGE ANALYSIS; LIVER FAILURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; REVIEW; WHITE MATTER;

BRAIN; BRAIN EDEMA; DIFFUSION MAGNETIC RESONANCE IMAGING; DOMINANCE, CEREBRAL; GLOBUS PALLIDUS; HEPATIC ENCEPHALOPATHY; HUMANS; HYPERAMMONEMIA; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MANGANESE; MESENCEPHALON; NEUROLOGIC EXAMINATION; SENSITIVITY AND SPECIFICITY;

EID: 54249128893     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1139     Document Type: Review

References (117)

1. Cordoba J, Blei AT. Hepatic encephalopathy. In: Shiff ER, Sorrell MF, Maddrey WC, eds. Shiff's Diseases of the Liver. Philadelphia: Lippincott Williams & Wilkins; 2003:595-623
2. Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy: definition, nomenclature, diagnosis, and quantification - final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-21
3. Weissenborn K. Diagnosis of encephalopathy. Digestion 1998;59(suppl 2):22-24
4. Cadranel JF, Lebiez E, Di Martino V, et al. Focal neurological signs in hepatic encephalopathy in cirrhotic patients: an underestimated entity? Am J Gastroenterol 2001;96:515-18
5. Joebges EM, Heidemann M, Schimke N, et al. Bradykinesia in minimal hepatic encephalopathy is due to disturbances in movement initiation. J Hepatol 2003;38:273-80
6. Krieger S, Jauss M, Jansen O, et al. Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis. Gastroenterology 1996;111:147-55
7. Adams RD, Foley JM. The neurological disorder associated with liver disease. Res Publ Assoc Res Nerv Ment Dis 1953;32:198-237
8. Ortiz M, Jacas C, Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol 2005;42(suppl 1):S45-S53
9. Amodio P, Montagnese S, Gatta A, et al. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 2004;19:253-67
10. Weissenborn K, Ennen JC, Schomerus H, et al. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001;34:768-73
11. Weissenborn K, Bokemeyer M, Ahl B, et al. Functional imaging of the brain in patients with liver cirrhosis. Metab Brain Dis 2004;19:269-80
12. Albrecht J, Jones EA. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J Neurol Sci 1999;170:138-46
13. Butterworth RF. The neurobiology of hepatic encephalopathy. Semin Liver Dis 1996;16:235-44
14. Hazell AS. Astrocytes and manganese neurotoxicity. Neurochem Int 2002;41:271-77
15. Normandin L, Hazell AS. Manganese neurotoxicity: an update of pathophysiologic mechanisms. Metab Brain Dis 2002;17:375-87
16. Butterworth RF. Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis 2002;17:221-27
17. Rao KV, Norenberg MD. Cerebral energy metabolism in hepatic encephalopathy and hyperammonemia. Metab Brain Dis 2001;16:67-78
18. Papavasiliou PS, Miller ST, Cotzias GC. Role of liver in regulating distribution and excretion of manganese. Am J Physiol 1966;211:211-16
19. Stallings WC, Metzger AL, Pattridge KA, et al. Structure-function relationships in iron and manganese superoxide dismutases. Free Radic Res Commun 1991;12-13(Pt 1):259-68
20. Wedler FC, Tom R. Interactions of Mn (II) with mammalian glutamine synthetase. In: Schramm VL, Wedler FC, eds. Manganese in Metabolism and Enzyme Function. New York: Academic Press; 1986:221-38
21. Bentle LA, Lardy HA. Interaction of anions and divalent metal ions with phosphoenolpyruvate carboxykinase. J Biol Chem 1976;251:2916-21
22. Couper J. On the effects of black oxide of manganese when inhaled into the lungs. Br Ann Med Pharmacol 1837;1:41-42
23. Mena I, Marin O, Fuenzalida S, et al. Chronic manganese poisoning: clinical picture and manganese turnover. Neurology 1967;17:128-36
24. Barbeau A. Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias). Neurotoxicology 1984;5:13-35
25. Emara AM, el-Ghawabi SH, Madkour OI, et al. Chronic manganese poisoning in the dry battery industry. Br J Ind Med 1971;28:78-82
26. Yamada M, Ohno S, Okayasu I, et al. Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol 1986;70:273-78
27. Olanow CW, Good PF, Shinotoh H, et al. Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology 1996;46:492-98
28. Spadoni F, Stefani A, Morello M, et al. Selective vulnerability of pallidal neurons in the early phases of manganese intoxication. Exp Brain Res 2000;135:544-51
29. Rose C, Butterworth RF, Zayed J, et al. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 1999;117:640-44
30. Burkhard PR, Delavelle J, Pasquier RD, et al. Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration. Arch Neurol 2003;60:521-28
31. Olanow CW. Manganese-induced parkinsonism and Parkinson's disease. Ann N Y Acad Sci 2004;1012:209-23
32. Shulman LM, Minagar A, Weiner WJ. Reversal of parkinsonism following liver transplantation. Neurology 2003;60:519
33. Calne D, Chu N, Huang C, et al. Manganism and idiopathic parkinsonism: similarities and differences. Neurology 1994;44:1583-86
34. Klos KJ, Ahlskog JE, Josephs KA, et al. Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probable manganese neurotoxicity. Arch Neurol 2005;62:1385-90
35. Morgan MY. Noninvasive neuroinvestigation in liver disease. Semin Liver Dis 1996;16:293-314
36. Pujol A, Pujol J, Graus F, et al. Hyperintense globus pallidus on T1-weighted MRIin cirrhotic patients is associated with severity of liver failure. Neurology 1993;43:65-69
37. Krieger S, Jauss M, Jansen O, et al. MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation. J Hepatol 1997;27:121-26
38. Matsumoto S, Mori H, Yoshioka K, et al. Effects of portal-systemic shunt embolization on the basal ganglia: MRI. Neuroradiology 1997;39:326-28
39. Butterworth RF, Spahr L, Fontaine S, et al. Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy. Metab Brain Dis 1995;10:259-67
40. Spahr L, Butterworth RF, Fontaine S, et al. Increased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. Hepatology 1996;24:1116-20
41. Hauser RA, Zesiewicz TA, Rosemurgy AS, et al. Manganese intoxication and chronic liver failure. Ann Neurol 1994;36:871-75
42. Katsuragi T, Iseki E, Kosaka K, et al. Cerebrospinal fluid manganese concentrations in patients with symmetric pallidal hyperintensities on T1 weighted MRI. J Neurol Neurosurg Psychiatry 1999;66:551-52
43. Pomier-Layrargues G, Spahr L, Butterworth RF. Increased manganese concentrations in pallidum of cirrhotic patients. Lancet 1995;345:735
44. Krieger D, Krieger S, Jansen O, et al. Manganese and chronic hepatic encephalopathy. Lancet 1995;346:270-74
45. Mirowitz SA, Westrich TJ, Hirsch JD. Hyperintense basal ganglia on T1-weighted MR images in patients receiving parenteral nutrition. Radiology 1991;181:117-20
46. Nagatomo S, Umehara F, Hanada K, et al. Manganese intoxication during total parenteral nutrition: report of two cases and review of the literature. J Neurol Sci 1999;162:102-05
47. Mirowitz SA, Westrich TG. Basal ganglia signal intensity alterations: reversal after discontinuation of parenteral manganese administration. Radiology 1992;185:535-36
48. Ejima A, Imamura T, Nakamura S, et al. Manganese intoxication during total parenteral nutrition. Lancet 1992;339:426
49. Josephs KA, Ahlskog JE, Klos KJ, et al. Neurologic manifestations in welders with pallidal MRI T1 hyperintensity. Neurology 2005;64:2033-39
50. Nolte W, Wiltfang J, Schindler CG, et al. Bright basal ganglia in T1-weighted magnetic resonance images are frequent in patients with portal vein thrombosis without liver cirrhosis and not suggestive of hepatic encephalopathy. J Hepatol 1998;29:443-49
51. M?́nguez B, Garc?́a-Pagán JC, Bosch J, et al. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy. Hepatology 2006;43:707-14
52. Ortiz M, Córdoba J, Alonso J, et al. Oral glutamine challenge and magnetic resonance spectroscopy in three patients with congenital portosystemic shunts. J Hepatol 2004;40:552-57
53. Devenyi AG, Barron TF, Mamourian AC. Dystonia, hyperintense basal ganglia, and high whole blood manganese levels in Alagille's syndrome. Gastroenterology 1994;106:1068-71
54. Lai PH, Chen C, Liang HL, et al. Hyperintense basal ganglia on T1-weighted MR imaging. AJR Am J Roentgenol 1999;172:1109-15
55. Lockwood AH, Weissenborn K, Butterworth RF. An image of the brain in patients with liver disease. Curr Opin Neurol 1997;10:525-33
56. Weissenborn K, Ehrenheim C, Hori A, et al. Pallidal lesions in patients with liver cirrhosis: clinical and MRI evaluation. Metab Brain Dis 1995;10:219-31
57. Córdoba J, Alonso J, Rovira A, et al. The development of low-grade cerebral edemain cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J Hepatol 2001;35:598-604
58. Cordoba J, Olive G, Alonso J, et al. Improvement of magnetic resonance spectroscopic abnormalities but not pallidal hyperintensity followed amelioration of hepatic encephalopathy after occlusion of a large spleno-renal shunt. J Hepatol 2001;34:176-78
59. Naegele T, Grodd W, Viebahn R, et al. MR imaging and 1H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation. Radiology 2000;216:683-91
60. Cooper JL, Plum F. Biochemistry and physiology of brain ammonia. Physiol Rev 1987;67:440-519
61. Lockwood AH, Yap EW, Wong WH. Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cereb Blood Flow Metab 1991;11:337-41
62. Norenberg MD. Astroglial dysfunction in hepatic encephalopathy. Metab Brain Dis 1998;13:319-35
63. Martinez-Hernandez A, Bell KP, Norenberg MD. Glutamine synthetase: glial localization in brain. Science 1977;195:1356-85
64. Donovan JP, Shafer DF, Shaw BW Jr, et al. Cerebral oedema and increased intracranial pressure in chronic liver disease. Lancet 1998;351:719-21
65. McManus ML, Churchwell KB, Strange K. Regulation of cell volume in health and disease. N Engl J Med 1995;333:1260-66
66. Butterworth RF, Giguere JF, Michaud J, et al. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol 1987;6:1-12
67. Haussinger D, Laubenberger J, Dahl S, et al. Proton magnetic resonance spectroscopy studies on human brain myoinositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology 1994;107:1475-80
68. Lee JH, Seo DW, Lee Y, et al. Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve. Am J Gastroenterol 1999;94:2206-13
69. Laubenberger J, Häussinger D, Bayer S, et al. Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology 1997;112:1610-16
70. Geissler A, Lock G, Fründ R, et al. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Hepatology 1997;25:48-54
71. Ross BD, Jacobson S, Villamil F, et al. Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 1994;193:457-63
72. Kreis R, Ross BD, Farrow NA, et al. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992;182:19-27
73. Köstler H. Proton magnetic resonance spectroscopy in portal-systemic encephalopathy. Metab Brain Dis 1998;13:291-301
74. Córdoba J, Gottstein J, Blei AT. Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: implications for ammonia-induced brain edema. Hepatology 1996;24:919-23
75. Thomas MA, Huda A, Guze B, et al. Cerebral 1H MR spectroscopy and neurophsychologic status of patients with hepatic encephalopathy. AJR Am J Roentgenol 1998;171:1123-30
76. Cordoba J, Raguer N, Flavia M, et al. T2 hyperintensity along the corticospinal tract in cirrhosis relates to functional abnormalities. Hepatology 2003;38:1026-33
77. Córdoba J, Blei AT. Brain edema and hepatic encephalopathy. Semin Liver Dis 1996;16:271-80
78. Haussinge D, Kircheis G, Fischer R, et al. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? J Hepatol 2000;32:1035-38
79. Jalan R, Dabos K, Redhead DN, et al. Elevation of intracranial pressure following transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol 1997;27:928-33
80. Swain MS, Blei AT, Butterworth RF, et al. Intracellular pH rises in astrocytes swell after portocaval anastomosis in rats. Am J Physiol 1991;261:R1491-96
81. Norenberg MD. The astrocyte in liver disease. In: Fedoroff S, Hertz L, eds. Advances in Cellular Neurobiology. New York: Academic Press; 1981:303-52
82. Iwasa M, Kinosada Y, Nakatsuka A, et al. Magnetization transfer contrast of various regions of the brain in liver cirrhosis. AJNR Am J Neuroradiol 1999;20:652-54
83. Rovira A, Grivé E, Pedraza S, et al. Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis. AJNR Am J Neuroradiol 2001;22:1137-42
84. Rovira A, Cordoba J, Sanpedro F, et al. Normalization of T2 signal abnormalities in hemispheric white matter with liver transplant. Neurology 2002;9:335-41
85. Lodi R, Tonon C, Stracciari A, et al. Diffusion MRI shows increased water apparent diffusion coefficient in the brains of cirrhotics. Neurology 2004;62:762-66
86. Kale RA, Gupta RK, Saraswat VA, et al. Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology 2006;43:698-706
87. Wolf SD, Balaban RS. Magnetization transfer imaging: practical aspects and clinical applications. Radiology 1994;192:593-99
88. Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182:483-91
89. Dousset V, Brochet B, Vital A, et al. Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer. AJNR Am J Neuroradiol 1995;16:225-31
90. Dousset V, Armand JP, Lacoste D, et al. Magnetization transfer study of HIV encephalitis and progressive multifocal leukoencephalopathy. AJNR Am J Neuroradiol 1997;18:895-901
91. van Waesberghe JH, van Walderveen MA, Castelijns JA, et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR Am J Neuroradiol 1998;19:675-83
92. Rovira A, Alonso J, Cucurella G, et al. Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images. AJNR Am J Neuroradiol 1999;20:1939-45
93. Iwasa M, Kinosada Y, Watanabe S, et al. Hepatic cirrhosis: magnetization transfer contrast in globus pallidus. Neuroradiology 1998;40:145-49
94. Lee YC, Markus R, Hughes A. MRI in ALS: corticospinal tract hyperintensity. Neurology 2003;61:1600
95. Rydberg JN, Hammond CA, Grimm RC, et al. Initial experience in MR imaging of the brain with a fast fluid-attenuated inversion-recovery pulse sequence. Radiology 1994;193:173-80
96. Mirowitz S, Sartor K, Gado M, et al. Focal signal-intensity variations in the posterior internal capsule: normal MR findings and distinction from pathological findings. Radiology 1989;172:535-39
97. Gawne-Cain ML, Silver NC, Moseley IF, et al. Fast FLAIR of the brain: the range of appearances in normal subjects and its application to quantification of white-matter disease. Neuroradiology 1997;39:243-49
98. Patel N, White S, Dhanjal NS, et al. Changes in brain size in hepatic encephalopathy: a coregistered MRI study. Metab Brain Dis 2004;19:431-45
99. Sarchielli P, Pelliccioli GP, Tarducci R, et al. Magnetic resonance imaging and 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. Neuroradiology 2001;43:189-97
100. Shaw PJ, Eggett CJ. Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis. J Neurol 2000;247:17-27
101. Vogels BA, Maas MA, Daalhuisen J, et al. Memantine, an non-competitive NMDA-receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats. Hepatology 1997;25:820-27
102. Knecht K, Michalak A, Rose C, et al. Decreased glutamate transporter (GLT-1) expression in frontal cortex of rats with acute liver failure. Neurosci Lett 1997;229:201-03
103. Weber M, Eisen AA. Magnetic stimulation of the central and peripheral nervous systems. Muscle Nerve 2002;25:160-75
104. de Leeuw FE, de Groot JC, Achten E, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study - The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001;70:9-14
105. M?́nguez B, Rovira A, Alonso J, et al. Decrease in the volume of white matter lesions with improvement of hepatic encephalopathy. AJNR Am J Neuroradiol 2007;28:1499-500
106. Rovira A, M?́nguez B, Córdoba J, et al. Decreased white matter lesion volume and improved cognitive function following liver transplantation. Hepatology 2007;46:1485-90
107. Schmidt R, Enzinger C, Ropele S, et al, for the Austrian Stroke Prevention Study. Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study. Lancet 2003;361:2046-48
108. Taylor WD, MacFall JR, Provenzale JM, et al. Serial MR imaging of volumes of hyperintense white matter lesions in elderly patients: correlation with vascular risk factors. AJR Am J Roentgenol 2003;181:571-76
109. Dufouil C, Chalmers J, Coskun O, et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 2005;112:1644-50. Epub 2005 Sep 6
110. Miese F, Kircheis G, Wittsack HJ, et al. 1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy. AJNR Am J Neuroradiol 2006;27:1019-26
111. Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology 2000;217:331-45
112. Ziylan YZ, Uzum G, Bernard G, et al. Changes in the permeability of the blood-brain barrier in acute hyperammonemia: effect of dexamethasone. Mol Chem Neuropathol 1993;20:203-18
113. Hazell AS, Normandin L, Norenberg MD, et al. Alzheimer type II astrocytic changes following sub-acute exposure to manganese and its prevention by antioxidant treatment. Neurosci Lett 2006;396:167-71
114. Sobel RA, DeArmond SJ, Forno LS, et al. Glial fibrillary acidic protein in hepatic encephalopathy: an immunohistochemical study. J Neuropathol Exp Neurol 1981;40:625-32
115. Eng LF, Ghirnikar RS, Lee YL. Glial fibrillary acidic protein: GFAP-thirty-one years (1969 -2000). Neurochem Res 2000;25:1439-51
116. Chen KC, Nicholson C. Changes in brain cell shape create residual extracellular space volume and explain tortuosity behavior during osmotic challenge. Proc Natl Acad Sci U S A 2000;97:8306-11
117. Ranjan P, Mishra AM, Kale R, et al. Cytotoxic edema is responsible for raised intracranial pressure in fulminant hepatic failure: in vivo demonstration using diffusion-weighted MRI in human subjects. Metab Brain Dis 2005;20:181-92